• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Market and Future Potential for Molecular Point of Care (POC), 2022

$5,000.00 – $10,000.00

Clear
SKU: 22-018 Categories: Diagnostics Market Research, Point-of-Care Diagnostics Tags: molecular point-of-care market, mPOC Flu, mPOC RSV, mPOC Strep, Near Patient Molecular IVD Market, Respiratory Segment Breakout, Small-Footprint Molecular Point of Care Market Pages: 128
  • Description
  • Table of Contents
  • Latest reports

Description

The Market and Future Potential for Molecular Point of Care (POC), 2022 provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting.

Molecular point of care or mPOC systems are designed to be faster than lab-based tests while more accurate than existing point of care systems. Development of new systems and menu expansion on existing lines is constant. Kalorama Information defines molecular point of care or mPOC as consisting of devices marketed to customers outside the reference lab that run PCR or other DNA and RNA testing on a device with a small footprint. mPOC systems tend to have a result time fast enough for an office visit or bedside consultation. These systems feature cartridges or reduced preparation steps and limited interpretation of test results.

This was a subset of the testing industry still proving its merit to customers early last year, but certainly the ongoing COVID-19 pandemic has been an influence on the market, as we covered in recent reports. The ability to deliver rapid PCR results has put them in the right place with the right function at the right time.  This report features a complete update on mPOC and COVID-19. It also discusses other growth areas.

The data in The Market and Future Potential for Molecular Point of Care (POC), 2022 includes information on systems and competitor analysis, as well as data on the size and growth of the market:

  • Current Molecular POC Systems
  • Molecular Point of Care Market: 2021-2026
  • COVID mPOC Market
  • Molecular Point of Care Market Share by Vendor, 2021 ($M, %)
  • Small-Footprint Molecular Point of Care Market, 2021 (%)
  • Geographic Breakout of the Molecular Point of Care Market, 2021 (N. America, Europe, APAC, RoW)
  • Segment Breakout of Molecular Point of Care Market, 2021 (Respiratory vs. Other)
  • Breakout of Molecular Point of Care Market, 2021 (%; Respiratory, Other)
  • Respiratory Segment Breakout, 2021 (Flu, RSV, Strep, Other)
  • Breakout of mPOC Respiratory, 2021 (%; Flu, Strep, RSV, Other)
  • Near Patient Molecular IVD Market: 2021-2026
  • Near Patient Molecular Market Share by Vendor, 2021
  • Company Profiles

Many trends are covered in the report, including menu expansion, disease statistics, the COVID-19 crisis, immunoassay competition and enhancement of those competitive POC systems, emerging markets, new journal studies about the efficacy of mPOC and other trends.

Companies profiled include:

  • Abbott Laboratories
  • Aidian Oy
  • Akonni Biosystems
  • binx health, inc.
  • Biocartis NV
  • bioMérieux SA
  • Cepheid
  • Credo Bioscience
  • Curetis NV
  • DiaSorin S.p.A
  • GenMark Diagnostics
  • Greiner Bio-One GmbH
  • Meridian Bioscience, Inc.
  • Mesa Biotech, Inc.
  • QIAGEN NV
  • QuantuMDx Group
  • Quidel Corporation
  • Roche
  • Sekisui Diagnostics LLC
  • T2 Biosystems

Table of Contents

Chapter One: Executive Summary

  • Figure 1-1: Molecular Point of Care Market, 2021-2026

Where is Molecular Point of Care in 2021?

Molecular Point of Care Market Analysis

  • Figure 1-2: mPOC Market by Disease Indication, 2020 (%; Respiratory, Other)

Market Observations

“Near-Patient” Molecular Systems Market

  • Figure 1-3: mPOC and Near-Patient Market, 2021-2026
  • Table 1-1: Near Patient Molecular Systems Market: 2021-2026 ($M)

Current Trends

Molecular Point-of-Care Diagnostics Defined

Usage of Molecular Point of Care

Leading mPOC Platforms

  • Table 1-2: Molecular POC Diagnostic Platforms/ Technologies

Trends

Scope and Methodology

 

Chapter Two: Molecular Point-of-Care Market Development and Trends

COVID-19 and Molecular POC

  • Table 2-1: Molecular POC COVID-19 Emergency Authorizations

CDC Initial Response, Long Term Situation

COVID-19’s Unique Challenge

BARDA Directs Funding to mPOC

Recent Regulatory Developments

Consortia, Funding, Prizes

Deals

  • Table 2-2: Deals in Molecular Point of Care

Advantages and Disadvantages of Molecular Point of Care

  • Table 2-3: Disadvantages of Molecular Point of Care, by Setting

Justification: The Sensitivity/Specificity Argument

New Systems and Menu Expansion

Mesa Biotech Strep A Approval

Combination Tests Enter Market: SARS-CoV-2, Flu A, Flu B, and RSV

STI Continues to Be a Growth Area

Deals, Investment in mPOC Systems

Thermo Acquires Mesa Biotech

EU Researchers Awarded €3M to Develop POC Molecular Tests

Scope Fluidics AST System Sees Investment

China as a POC Market

Common Tests and Analytes in POC Diagnostics

Component Technologies of Molecular Point-of-Care Diagnostics

Microfluidics

qPCR

Microarrays

Isothermal Amplification

Test Automation

Primers and Probes

Detection

Next-Generation Sequencing

Molecular Diagnostics

Real-Time PCR (qPCR)

Isothermal Amplification Methods

Line Probe Assays

Next-Generation Sequencing

Applications and Potential Applications for Molecular Point-of-Care

Major Testing Applications for Molecular POC Diagnostics

Influenza

Reclassification of RIDTs

Hospital-Acquired Infections (HAIs)

Strep A

Respiratory Syncytial Virus (RSV)

Emerging Applications

Zika

Other Respiratory Infections

Group B Streptococcus

Human Papillomavirus

Herpes Simplex Virus

Vaginitis

Malaria

Other Tropical and Neglected Diseases

Cancer

European Device Regulations Nearing

 

Chapter Three: Market Analysis

Molecular Point of Care Market Analysis

  • Table 3-1: Molecular Point of Care Market: 2021-2026
  • Table 3-2: Molecular Point of Care Market Share by Vendor, 2021 ($M, %)
  • Figure 3-1: Molecular Point of Care Market Share by Vendor, 2021 (%)
  • Table 3-3: Geographic Breakout of the Molecular Point of Care Market, 2021 (N. America, Europe, APAC, RoW)
  • Table 3-4: Segment Breakout of Molecular Point of Care Market, 2021 (Respiratory vs. Other)
  • Figure 3-2: Breakout of Molecular Point of Care Market, 2021 (%; Respiratory, Other)

“Near Patient Molecular” Market

  • Table 3-5: Near Patient Molecular Systems Market: 2021-2026

Market Share Near Patient

  • Figure 3-3:  Market Share, Near Patient Molecular Testing, 2021

 

Chapter Four: Company Profiles

Abbott Laboratories

Aidian Oy

Akonni Biosystems

binx health, inc.

Biocartis NV

bioMérieux SA

Cepheid (Danaher)

Molecular Healthcare-Acquired Infection (HAI) Testing

Molecular Sexual Health and Women’s Health Testing

Molecular Critical Infectious Disease Testing

Molecular Oncology/Genetics Testing

Credo Diagnostics

Curetis NV (OpGen)

DiaSorin S.p.A

GenMark Diagnostics (Roche)

Greiner Bio-One GmbH

Meridian Bioscience, Inc.

Mesa Biotech, Inc. (Thermo)

QIAGEN NV

QuantuMDx Group

Quidel Corporation

Roche

Sekisui Diagnostics LLC

T2 Biosystems

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00
  • Placeholder image

    Biophotonics – A Strategic Assessment of Photonics Technologies for Biomedical Applications

    $2,995.00 – $5,990.00
  • Placeholder image

    Cell-Based Diagnostics: Technology, Applications, and Markets

    $3,500.00 – $7,000.00
  • Placeholder image

    Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

    $2,625.00 – $5,250.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
IVD Trends and Market Update, March 2022At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and...
Scroll to top